Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLKO-shp38 Citations (3)

Originally described in: p38MAPK plays a crucial role in stromal mediated tumorigenesis.
Alspach E, Flanagan KC, Luo X, Ruhland MK, Huang H, Pazolli E, Donlin MJ, Marsh T, Piwnica-Worms D, Monahan J, Novack DV, McAllister SS, Stewart SA Cancer Discov. 2014 Mar 26.
PubMed Journal

Articles Citing pLKO-shp38

Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis. Xi XJ, Zeng JJ, Lu Y, Chen SH, Jiang ZW, He PJ, Mi H. J Cell Mol Med. 2020 May 22. doi: 10.1111/jcmm.15397. PubMed
miRNA-34c Suppresses Osteosarcoma Progression In Vivo by Targeting Notch and E2F. Bae Y, Zeng HC, Chen YT, Ketkar S, Munivez E, Yu Z, Gannon FH, Lee BH. JBMR Plus. 2022 Apr 9;6(5):e10623. doi: 10.1002/jbm4.10623. eCollection 2022 May. PubMed
LRIG2 promotes glioblastoma progression by modulating innate antitumor immunity through macrophage infiltration and polarization. Hu J, Dong F, He Y, Xia X, Cheng F, Chen S, Hou X, Zhang P, Liu G, Li Y, Gao Q, Dong M, Li T, Li W, Xiao Q, Li X, Yu X, Xi G, Guo D, Wu X, Wang B. J Immunother Cancer. 2022 Sep;10(9):e004452. doi: 10.1136/jitc-2021-004452. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.